FrancophonIA/ELRC3.0 huggingface dataset:
English: You should also tell your doctor:  if you are on a low-salt diet if you have signs such as abnormal thirst, dry mouth, general weakness, drowsiness, muscle pain or cramps, nausea, vomiting, or an abnormally fast heart beat which may indicate an excessive effect of hydrochlorothiazide (contained in Karvezide) if you experience an increased sensitivity of the skin to the sun with symptoms of sunburn (such as redness, itching, swelling, blistering) occurring more quickly than normal if you are going to have an operation (surgery) or be given anaesthetics if you have changes in your vision or pain in one or both of your eyes while taking Karvezide.
Croatian: Svog liječnika također trebate obavijestiti: ako ste na dijeti s malim unosom soli ako imate simptome kao što su neuobičajena žeđ, suha usta, opća slabost, omamljenost, grčevi ili bol u mišićima, mučnina, povraćanje ili neuobičajeno brzi otkucaji srca jer oni mogu upućivati na pretjerani učinak hidroklorotiazida (sastojak lijeka Karvezide) ako iskusite povećanu osjetljivost kože na sunce s pojavom simptoma sunčanih opeklina (kao što su crvenilo kože, svrbež, oticanje, nastanak mjehurića), a pojavljuju se brže nego što je normalno ako trebate ići na operaciju (kirurški zahvat) ili trebate primiti anestetike ako tijekom uzimanja lijeka Karvezide primijetite promjene vida ili bol u jednom ili oba oka.
English: These lesions were not observed in macaques;  decreases in serum potassium due to hydrochlorothiazide and partly prevented when hydrochlorothiazide was given in combination with irbesartan.
Croatian: smanjenje razine kalija u serumu koje izaziva hidroklorotiazid djelomično je smanjeno kad se hidroklorotiazid davao u kombinaciji s irbesartanom.
English: Karvezide is a combination of an angiotensin-II receptor antagonist, irbesartan, and a thiazide diuretic, hydrochlorothiazide.
Croatian: Karvezide je kombinacija irbesartana, antagonista receptora angiotenzina II, i hidroklorotiazida, tiazidskog diuretika.
English: Karvezide is for oral use.
Croatian: Karvezide je namijenjen za primjenu kroz usta.
English: Dual blockade of the renin-angiotensin-aldosterone system (RAAS) Two large randomised, controlled trials (ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) and VA NEPHRON-D (The Veterans Affairs Nephropathy in Diabetes)) have examined the use of the combination of an ACE-inhibitor with an angiotensin II receptor blocker.
Croatian: ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) i VA NEPHRON-D (eng. The Veterans Affairs Nephropathy in Diabetes)) ispitivala su primjenu kombinacije ACE inhibitora s blokatorom angiotenzin II receptora.
English: When measured by ambulatory blood pressure monitoring, the trough to peak effects of Karvezide 150 mg/12.5 mg were 100%.
Croatian: Na osnovi ambulantnih mjerenja krvnog tlaka, učinci najniže i najviše koncentracije pri primjeni lijeka Karvezide 150 mg/12,5 mg iznosili su 100%.
English: The following changes, observed in rats and macaques receiving the irbesartan/hydrochlorothiazide combination at 10/10 and 90/90 mg/kg/day, were also seen with one of the two medicinal products alone and/or were secondary to decreases in blood pressure (no significant toxicologic interactions were observed):  kidney changes, characterized by slight increases in serum urea and creatinine, and hyperplasia/hypertrophy of the juxtaglomerular apparatus, which are a direct consequence of the interaction of irbesartan with the renin-angiotensin system;  slight decreases in erythrocyte parameters (erythrocytes, haemoglobin, haematocrit);  stomach discoloration, ulcers and focal necrosis of gastric mucosa were observed in few rats in a 6 months toxicity study at irbesartan 90 mg/kg/day, hydrochlorothiazide 90 mg/kg/day, and irbesartan/hydrochlorothiazide 10/10 mg/kg/day.
Croatian: Sljedeće promjene, zabilježene kod štakora i makaki majmuna, koji su dobivali kombinaciju irbesartan/hidroklorotiazid u dozama od 10/10 i 90/90 mg/kg/dan, također su uočene i kod pojedinačne primjene ovih lijekova i/ili su bile sekundarne sniženju krvnog tlaka (nisu zabilježene značajne toksikološke interakcije): promjene funkcije bubrega, karakterizirane blagim porastom razine ureje i kreatinina u serumu kao i hiperplazija/hipertrofija jukstaglomerularnog aparata, što je izravna posljedica interakcije irbesartana s renin-angiotenzinskim sustavom; blago sniženje eritrocitnih parametara (eritrociti, hemoglobin, hematokrit); diskoloracija želuca, ulceracije i fokalna nekroza sluznice želuca, primijećene su u nekoliko štakora tijekom šestomjesečnog istraživanja toksičnosti nakon doza od 90 mg/kg/dan irbesartana, 90 mg/kg/dan hidroklorotiazida te kombinacije irbesartan/hidroklorotiazid od 10/10 mg/kg/dan; te lezije nisu zabilježene kod makaki majmuna;
English: If you take more Karvezide than you should If you accidentally take too many tablets, contact your doctor immediately.
Croatian: Ako slučajno uzmete previše tableta, odmah se obratite svome liječniku.
English: Aliskiren-containing products or ACE-inhibitors: clinical trial data has shown that dual blockade of the renin-angiotensin-aldosterone system (RAAS) through the combined use of ACE-inhibitors, angiotensin II receptor blockers or aliskiren is associated with a higher frequency of adverse events such as hypotension, hyperkalaemia and decreased renal function (including acute renal failure) compared to the use of a single RAAS-acting agent (see sections 4.3, 4.4 and 5.1).
Croatian: Lijekovi koji sadrže ili ACE inhibitore: podaci iz kliničkih ispitivanja pokazali su da je dvostruka blokada renin-angiotenzin-aldosteronskog sustava (RAAS) kombiniranom primjenom ACE inhibitora, blokatora angiotenzin II receptora ili aliskirena povezana s većom učestalošću štetnih događaja kao što su hipotenzija, hiperkalemija i smanjena bubrežna funkcija (uključujući akutno zatajenje bubrega) u usporedbi s primjenom samo jednog lijeka koji djeluje na RAAS (vidjeti dijelove 4.3, 4.4 i 5.1).
English: Irbesartan/hydrochlorothiazide combination:
Croatian: Irbesartan/hidroklorotiazid u kombinaciji
English: If you are taking an ACE-inhibitor or aliskiren (see also information under the headings “Do not take Karvezide” and “Warnings and precautions”).
Croatian: “Nemojte uzimati Karvezide” i “Upozorenja i mjere opreza“).
English: Medicinal products affected by serum potassium disturbances: periodic monitoring of serum potassium is recommended when Karvezide is administered with medicinal products affected by serum potassium disturbances (e.g. digitalis glycosides, antiarrhythmics).
Croatian: Lijekovi na koje utječu poremećaji razine kalija u serumu: pri istodobnoj primjeni lijeka Karvezide i drugih lijekova na čije djelovanje utječu poremećaji kalija (primjerice glikozidi digitalisa, antiaritmici) preporučuje se periodičko praćenje razine kalija u serumu.
English: Fever
Croatian: vrućica
English:  if you suffer from heart problems  if you suffer from liver problems  if you suffer from diabetes if you suffer from lupus erythematosus (also known as lupus or SLE) if you suffer from primary aldosteronism (a condition related to high production of the hormone aldosterone, which causes sodium retention and, in turn, an increase in blood pressure).
Croatian: ako značajno povraćate ili imate jaki proljev ako imate problema s bubrezima ili ste imali transplantaciju bubrega ako imate srčanih problema ako imate problema s jetrom ako bolujete od šećerne bolesti ako bolujete od eritemskog lupusa (poznat i kao lupus ili SLE) ako bolujete od primarnog aldosteronizma (stanje povezano s visokom proizvodnjom hormona aldosterona, koji uzrokuje zadržavanje natrija u tijelu i, posljedično, povećanje krvnog tlaka) ako uzimate bilo koji od lijekova navedenih u nastavku, koji se koriste za liječenje visokog krvnog tlaka: ACE inhibitor (primjerice enalapril, lisinopril, ramipril), osobito ako imate bubrežne tegobe povezane sa šećernom bolešću. aliskiren.
English:  The other ingredients are microcrystalline cellulose, croscarmellose sodium, lactose monohydrate, magnesium stearate, colloidal hydrated silica, pregelatinised maize starch, red and yellow ferric oxides (E172).
Croatian: Drugi sastojci su mikrokristalična celuloza, umrežena karmelozanatrij, laktoza hidrat, magnezijev stearat, koloidni hidratizirani silicijev dioksid, prethodno geliran kukuruzni škrob, crveni i žuti željezov oksid (E172).
English: Unless continued
Croatian: Manje od
English: Uncommon side effects -may affect up to 1 in 100 people): diarrhoea low blood pressure fainting heart rate increased flushing swelling sexual dysfunction (problems with sexual performance) blood tests may show lowered levels of potassium and sodium in your blood.
Croatian: Manje česte nuspojave (mogu se javiti u manje od 1 na 100 osoba) proljev nizak krvni tlak nesvjestica ubrzani otkucaji srca crvenilo praćeno osjećajem vrućine oticanje seksualna disfunkcija (problemi sa seksualnom izvedbom) krvne pretrage mogu pokazati smanjene vrijednosti kalija i natrija u krvi Ako Vam neka od navedenih nuspojava uzrokuje tegobe, obratite se svome liječniku.
English: Excipient with known effect: Each film-coated tablet contains 89.5 mg of lactose (as lactose monohydrate).
Croatian: Jedna filmom obložena tableta sadrži 89,5 mg laktoze (u obliku laktoze hidrata).
English: Excipient with known effect: Each film-coated tablet contains 53.3 mg of lactose (as lactose monohydrate).
Croatian: Jedna filmom obložena tableta sadrži 53,3 mg laktoze (u obliku laktoze hidrata).
English: Karvezide 300 mg/25 mg film-coated tablets.
Croatian: NAZIV LIJEKA Karvezide 300 mg/25 mg filmom obložene tablete
English:  The other ingredients are lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, hypromellose, silicon dioxide, magnesium stearate, titanium dioxide, macrogol 3350, red, yellow and black ferric oxides, pregelatinised starch, carnauba wax.
Croatian: Drugi sastojci su laktoza hidrat, mikrokristalična celuloza, umrežena karmelozanatrij, hipromeloza, silicijev dioksid, magnezijev stearat, titanijev dioksid, makrogol 3350, crveni, žuti i crni željezov oksid, prethodno gelirani škrob, karnauba vosak.
English:  The other ingredients are lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, hypromellose, silicon dioxide, magnesium stearate, titanium dioxide, macrogol 3000, red and yellow ferric oxides, carnauba wax.
Croatian: Ostali sastojci su laktoza hidrat, mikrokristalična celuloza, umrežena karmelozanatrij, hipromeloza, silicijev dioksid, magnezijev stearat, titanijev dioksid, makrogol 3000, crveni i žuti željezov oksid, karnauba vosak.
English: No dosage adjustment of Karvezide is necessary in patients with mild to moderate hepatic impairment (see section 4.3).
Croatian: Za bolesnike s blagim ili umjerenim oštećenjem funkcije nije potrebna prilagodba doze lijeka Karvezide (vidjeti dio 4.3).
English: Excipient with known effect: Each tablet contains 26.65 mg of lactose (as lactose monohydrate).
Croatian: Jedna tableta sadrži 26,65 mg laktoze (u obliku laktoze hidrata).
English: Each film-coated tablet of Karvezide 300 mg/25 mg contains 300 mg irbesartan and 25 mg hydrochlorothiazide.
Croatian: Jedna Karvezide 300 mg/25 mg filmom obložena tableta sadrži 300 mg irbesartana i 25 mg hidroklorotiazida.
English: (It is also better to avoid Karvezide in early pregnancy - see pregnancy section) if you have severe liver or kidney problems if you have difficulty in producing urine if your doctor determines that you have persistently high calcium or low potassium levels in your blood if you have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren.
Croatian: Nemojte uzimati Karvezide ako ste alergični na irbesartan ili neki drugi sastojak ovoga lijeka (naveden u dijelu 6.) ako ste alergični na hidroklorotiazid ili neki drugi lijek koji je derivat sulfonamida ako ste trudni više od 3 mjeseca (preporučuje se također izbjegavati Karvezide i u ranoj trudnoći - vidjeti dio o trudnoći) ako imate teških problema s jetrom ili bubrezima ako imate poteškoća sa stvaranjem urina ako liječnik utvrdi da imate stalno povišenu razinu kalcija ili nisku razinu kalija u krvi ako imate šećernu bolest ili oštećenu bubrežnu funkciju i liječite se lijekom za snižavanje krvnog tlaka koji sadrži aliskiren
English: Side effects reported since the launch of Karvezide Some undesirable effects have been reported since marketing of Karvezide.
Croatian: Neke su nuspojave prijavljene nakon stavljanja lijeka Karvezide na tržište.
English: Karvezide 150 mg/12.5 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets.
Croatian: Karvezide 150 mg/12,5 mg tablete dostupne su u blister pakiranjima od 14, 28, 56 ili 98 tableta.
English: Karvezide 300 mg/12.5 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets.
Croatian: Karvezide 300 mg/12,5 mg tablete dostupne su u blister pakiranjima od 14, 28, 56 ili 98 tableta.
English: Karvezide 300 mg/25 mg film-coated tablets irbesartan/hydrochlorothiazide
Croatian: Karvezide 300 mg/25 mg filmom obložene tablete irbesartan/hidroklorotiazid
English: Karvezide 300 mg/12.5 mg tablets.
Croatian: NAZIV LIJEKA Karvezide 300 mg/12,5 mg tablete
English: The trough to peak effects measured by cuff during office visits were 68% and 76% for Karvezide 150 mg/12.5 mg and Karvezide 300 mg/12.5 mg, respectively.
Croatian: Učinci najniže i najviše koncentracije na sniženje krvnog tlaka nakon primjene lijeka Karvezide 150 mg/12,5 mg odnosno Karvezide 300 mg/12,5 mg, prema mjerenjima manžetom za vrijeme kontrolnog pregleda, iznosili su 68% odnosno 76%.
English: Karvezide 300 mg/25 mg film-coated tablets are supplied in blister packs of 14, 28, 30, 56, 84, 90 or 98 film-coated tablets.
Croatian: Karvezide 300 mg/25 mg filmom obložene tablete dostupne su u blister pakiranjima od 14, 28, 30, 56, 84, 90 ili 98 filmom obloženih tabletatableta.
English: Each tablet of Karvezide 150 mg/12.5 mg contains 150 mg irbesartan and 12.5 mg hydrochlorothiazide.
Croatian: Jedna Karvezide 150 mg/12,5 mg tableta sadrži 150 mg irbesartana i 12,5 mg hidroklorotiazida.
English: Karvezide 150 mg/12.5 mg tablets.
Croatian: NAZIV LIJEKA Karvezide 150 mg/12,5 mg tablete
English: EU/1/98/085/008 - 14 tablets EU/1/98/085/004 - 28 tablets EU/1/98/085/005 - 56 tablets EU/1/98/085/010 - 56 x 1 tablets EU/1/98/085/006 - 98 tablets
Croatian: EU/1/98/085/008 - 14 tableta EU/1/98/085/004 - 28 tableta EU/1/98/085/005 - 56 tableta EU/1/98/085/010 - 56 x 1 tableta EU/1/98/085/006 - 98 tableta
English: What Karvezide contains  The active substances are irbesartan and hydrochlorothiazide.
Croatian: Djelatne tvari su irbesartan i hidroklorotiazid.
English: NAME OF THE MEDICINAL PRODUCT Karvezide 300 mg/25 mg tablets irbesartan/hydrochlorothiazide NAME OF THE MARKETING AUTHORISATION HOLDER sanofi-aventis groupe EXPIRY DATE
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI BLISTER ILI STRIP NAZIV LIJEKA Karvezide 300 mg/25 mg tablete irbesartan/hidroklorotiazid NAZIV NOSITELJA ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET sanofi-aventis groupe ROK VALJANOSTI
English: A total of 697 patients were randomized in a 2:1 ratio to either irbesartan/hydrochlorothiazide 150 mg/12.5 mg or to irbesartan 150 mg and systematically force titrated (before assessing the response to the lower dose) after one week toirbesartan/hydrochlorothiazide 300 mg/25 mg or irbesartan 300 mg, respectively.
Croatian: Randomizirano je ukupno 697 bolesnika, u omjeru 2:1, u skupinu koja je primala kombinaciju irbesartan/hidroklorotiazid 150 mg/12,5 mg ili u skupinu koja je primala irbesartan 150 mg.
English: Each tablet of Karvezide 300 mg/12.5 mg contains 300 mg irbesartan and 12.5 mg hydrochlorothiazide.
Croatian: Jedna Karvezide 300 mg/12,5 mg tableta sadrži 300 mg irbesartana i 12,5 mg hidroklorotiazida.
English: Excipient with known effect: Each tablet contains 65.8 mg of lactose (as lactose monohydrate).
Croatian: Jedna tableta sadrži 65,8 mg laktoze (u obliku laktoze hidrata).
English: NAME OF THE MEDICINAL PRODUCT Karvezide 150 mg/12.5 mg tablets irbesartan/hydrochlorothiazide NAME OF THE MARKETING AUTHORISATION HOLDER sanofi-aventis groupe EXPIRY DATE
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI BLISTER ILI STRIP NAZIV LIJEKA Karvezide 150 mg/12,5 mg tablete irbesartan/hidroklorotiazid NAZIV NOSITELJA ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET sanofi-aventis groupe ROK VALJANOSTI
English: Karvezide 150 mg/12.5 mg film-coated tablets are supplied in blister packs of 14, 28, 30, 56, 84, 90 or 98 film-coated tablets.
Croatian: Karvezide 150 mg/12,5 mg filmom obložene tablete dostupne su u blister pakiranjima od 14, 28, 30, 56, 84, 90 ili 98 filmom obloženih tableta.
English: EU/1/98/085/007 - 14 tablets EU/1/98/085/001 - 28 tablets EU/1/98/085/002 - 56 tablets EU/1/98/085/009 - 56 x 1 tablets EU/1/98/085/003 - 98 tablets
Croatian: EU/1/98/085/007 - 14 tableta EU/1/98/085/001 - 28 tableta EU/1/98/085/002 - 56 tableta EU/1/98/085/009 - 56 x 1 tableta EU/1/98/085/003 - 98 tableta
English: tongue or throat.
Croatian: Primjena kroz usta.
English: Each tablet contains 150 mg of irbesartan and 12.5 mg of hydrochlorothiazide.
Croatian: Jedna tableta sadrži 150 mg irbesartana i 12,5 mg hidroklorotiazida
English: Package leaflet: Information for the patient Karvezide 300 mg/25 mg film-coated tablets irbesartan/hydrochlorothiazide
Croatian: Uputa o lijeku: Informacija za bolesnika Karvezide 300 mg/25 mg filmom obložene tablete irbesartan/hidroklorotiazid
English: NAME OF THE MEDICINAL PRODUCT Karvezide 300 mg/12.5 mg tablets irbesartan/hydrochlorothiazide NAME OF THE MARKETING AUTHORISATION HOLDER sanofi-aventis groupe EXPIRY DATE
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI BLISTER ILI STRIP NAZIV LIJEKA Karvezide 300 mg/12,5 mg tablete irbesartan/hidroklorotiazid NAZIV NOSITELJA ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET sanofi-aventis groupe ROK VALJANOSTI
English: Karvezide 300 mg/12.5 mg film-coated tablets.
Croatian: NAZIV LIJEKA Karvezide 300 mg/12,5 mg filmom obložene tablete
English: What Karvezide looks like and contents of the pack Karvezide 300 mg/25 mg film-coated tablets are pink, biconvex, oval-shaped, with a heart debossed on one side and the number 2788 engraved on the other side.
Croatian: Karvezide 300 mg/25 mg filmom obložene tablete su bikonveksne, ovalne tablete boje breskve s utisnutom oznakom srca na jednoj i brojem 2788 na drugoj strani.
English: Each film-coated tablet of Karvezide 150 mg/12.5 mg contains 150 mg irbesartan and 12.5 mg hydrochlorothiazide.
Croatian: Jedna Karvezide 150 mg/12,5 mg filmom obložena tableta sadrži 150 mg irbesartana i 12,5 mg hidroklorotiazida.
English: Karvezide 150 mg/12.5 mg tablets irbesartan/hydrochlorothiazide
Croatian: Karvezide 150 mg/12,5 mg tablete irbesartan/hidroklorotiazid
English: Karvezide 300 mg/12.5 mg film-coated tablets are supplied in blister packs of 14, 28, 30, 56, 84, 90 or 98 film-coated tablets.
Croatian: Karvezide 300 mg/12,5 mg filmom obložene tablete dostupne su u blister pakiranjima od 14, 28, 30, 56, 84, 90 ili 98 filmom obloženih tableta.
English: EU/1/98/085/023 - 14 tablets EU/1/98/085/024 - 28 tablets EU/1/98/085/031 - 30 tablets EU/1/98/085/025 - 56 tablets EU/1/98/085/028 - 56 x 1 tablets EU/1/98/085/026 - 84 tablets EU/1/98/085/034 - 90 tablets EU/1/98/085/027 - 98 tablets
Croatian: EU/1/98/085/023 - 14 tableta EU/1/98/085/024 - 28 tableta EU/1/98/085/031 - 30 tableta EU/1/98/085/025 - 56 tableta EU/1/98/085/028 - 56 x 1 tableta EU/1/98/085/026 - 84 tableta EU/1/98/085/034 - 90 tableta EU/1/98/085/027 - 98 tableta
English: What Karvezide looks like and contents of the pack Karvezide 150 mg/12.5 mg film-coated tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2875 engraved on the other side.
Croatian: Karvezide 150 mg/12,5 mg filmom obložene tablete su bikonveksne, ovalne tablete boje breskve s utisnutom oznakom srca na jednoj i brojem 2875 na drugoj strani.
English: Each tablet contains 300 mg of irbesartan and 12.5 mg of hydrochlorothiazide.
Croatian: Jedna tableta sadrži 300 mg irbesartana i 12,5 mg hidroklorotiazida
English: Karvezide 150 mg/12.5 mg film-coated tablets.
Croatian: NAZIV LIJEKA Karvezide 150 mg/12,5 mg filmom obložene tablete
English: Karvezide 150 mg/12.5 mg film-coated tablets irbesartan/hydrochlorothiazide
Croatian: Karvezide 150 mg/12,5 mg filmom obložene tablete irbesartan/hidroklorotiazid
English: EU/1/98/085/011 - 14 tablets EU/1/98/085/012 - 28 tablets EU/1/98/085/029 - 30 tablets EU/1/98/085/013 - 56 tablets EU/1/98/085/014 - 56 x 1 tablets EU/1/98/085/021 - 84 tablets EU/1/98/085/032 - 90 tablets EU/1/98/085/015 - 98 tablets
Croatian: EU/1/98/085/011 - 14 tableta EU/1/98/085/012 - 28 tableta EU/1/98/085/029 - 30 tableta EU/1/98/085/013 - 56 tableta EU/1/98/085/014 - 56 x 1 tableta EU/1/98/085/021 - 84 tableta EU/1/98/085/032 - 90 tableta EU/1/98/085/015 - 98 tableta
English: EU/1/98/085/016 - 14 tablets EU/1/98/085/017 - 28 tablets EU/1/98/085/030 - 30 tablets EU/1/98/085/018 - 56 tablets EU/1/98/085/019 - 56 x 1 tablets EU/1/98/085/022 - 84 tablets EU/1/98/085/033 - 90 tablets EU/1/98/085/020 - 98 tablets
Croatian: EU/1/98/085/016 - 14 tableta EU/1/98/085/017 - 28 tableta EU/1/98/085/030 - 30 tableta EU/1/98/085/018 - 56 tableta EU/1/98/085/019 - 56 x 1 tableta EU/1/98/085/022 - 84 tableta EU/1/98/085/033 - 90 tableta EU/1/98/085/020 - 98 tableta
English: Each film-coated tablet of Karvezide 300 mg/12.5 mg contains 300 mg irbesartan and 12.5 mg hydrochlorothiazide.
Croatian: Jedna Karvezide 300 mg/12,5 mg filmom obložena tableta sadrži 300 mg irbesartana i 12,5 mg hidroklorotiazida.
English: What Karvezide looks like and contents of the pack Karvezide 300 mg/12.5 mg film-coated tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2876 engraved on the other side.
Croatian: Karvezide 300 mg/12,5 mg filmom obložene tablete su bikonveksne, ovalne tablete boje breskve s utisnutom oznakom srca na jednoj i brojem 2876 na drugoj strani.
English: Karvezide 300 mg/12.5 mg film-coated tablets irbesartan/hydrochlorothiazide
Croatian: Karvezide 300 mg/12,5 mg filmom obložene tablete irbesartan/hidroklorotiazid
English: What Karvezide looks like and contents of the pack Karvezide 150 mg/12.5 mg tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2775 engraved on the other side.
Croatian: Karvezide 150 mg/12,5 mg tablete su bikonveksne, ovalne tablete boje breskve s utisnutom oznakom srca na jednoj i brojem 2775 na drugoj strani.
English: Package leaflet: Information for the patient Karvezide 150 mg/12.5 mg tablets irbesartan/hydrochlorothiazide
Croatian: Uputa o lijeku: Informacija za bolesnika Karvezide 150 mg/12,5 mg tablete irbesartan/hidroklorotiazid
English: Package leaflet: Information for the patient Karvezide 150 mg/12.5 mg film-coated tablets irbesartan/hydrochlorothiazide
Croatian: Uputa o lijeku: Informacija za bolesnika Karvezide 150 mg/12,5 mg filmom obložene tablete irbesartan/hidroklorotiazid
English: Package leaflet: Information for the patient Karvezide 300 mg/12.5 mg tablets irbesartan/hydrochlorothiazide
Croatian: Uputa o lijeku: Informacija za bolesnika Karvezide 300 mg/12,5 mg tablete irbesartan/hidroklorotiazid
English: What Karvezide looks like and contents of the pack Karvezide 300 mg/12.5 mg tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2776 engraved on the other side.
Croatian: Karvezide 300 mg/12,5 mg tablete su bikonveksne, ovalne tablete boje breskve s utisnutom oznakom srca na jednoj i brojem 2776 na drugoj strani.
English: Package leaflet: Information for the patient Karvezide 300 mg/12.5 mg film-coated tablets irbesartan/hydrochlorothiazide
Croatian: Uputa o lijeku: Informacija za bolesnika Karvezide 300 mg/12,5 mg filmom obložene tablete irbesartan/hidroklorotiazid
English: Each film-coated tablet contains 300 mg of irbesartan and 25 mg of hydrochlorothiazide.
Croatian: KVALITATIVNI I KVANTITATIVNI SASTAV Jedna filmom obložena tableta sadrži 300 mg irbesartana i 25 mg hidroklorotiazida.
English: Karvezide 300 mg/12.5 mg tablets irbesartan/hydrochlorothiazide
Croatian: NAZIV LIJEKA Karvezide 300 mg/12,5 mg tablete irbesartan/hidroklorotiazid